Cargando…
D020 ROLE OF CELLULAR CASPASES AND THERAPEUTIC POTENTIAL OF A PAN-CASPASE INHIBITOR, EMRICASAN, IN COVID-19.
Autores principales: | Alpan, O., Gupta, R., Latterich, M., Hubka, M., Bukhari, Z., Ndhlovu, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566907/ http://dx.doi.org/10.1016/j.anai.2021.08.051 |
Ejemplares similares
-
Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies
por: Premeaux, Thomas A., et al.
Publicado: (2022) -
Practical challenges for functional validation of STAT1 gain of function genetic variants
por: Albuquerque, Adriana S, et al.
Publicado: (2023) -
Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non‐alcoholic fatty liver disease
por: Shiffman, Mitchell, et al.
Publicado: (2018) -
OUTCOMES AND IMPACT OF COVID-19 ON INFECTION DIAGNOSIS RATES AMONG PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES
por: Riaz, F., et al.
Publicado: (2022) -
Natural killer cells induce HIV-1 latency reversal after treatment with pan-caspase inhibitors
por: Furtado Milão, Joana, et al.
Publicado: (2022)